Quick Takeaways
- David E. Lazar filed SCHEDULE 13D for Indaptus Therapeutics Inc. Common Stock, $0.01 par value (INDP).
- Disclosed ownership: 98%.
- Date of event: 26 Feb 2026.
David E. Lazar - 26 Feb 2026 SCHEDULE 13D Report for Indaptus Therapeutics Inc. Common Stock, $0.01 par value (INDP)
- Filing Manager
- David E. Lazar
- Reporting Manager
- Lazar David E.
- Symbol
- INDP
- Shares outstanding
- 113,265,306 shares
- Disclosed Ownership
- 111,000,000 shares
- Ownership
- 98%
- Form type
- SCHEDULE 13D
- Filing time
- 02 Mar 2026, 17:20:52 UTC
- Date of event
- 26 Feb 2026
- Next filing
- 24 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"David E. Lazar disclosed 98% ownership in Indaptus Therapeutics Inc. Common Stock, $0.01 par value (INDP) on 26 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Mar 2026, 17:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lazar David E. | 98% | 111,000,000 | 111,000,000 | 0 | /s/ David E. Lazar | David E. Lazar | 0001932843 |